Deyta

What Deyta does

Deyta GmbH is a German digital health company operating the LONGEVITAL consumer application for longevity and healthspan optimization. Founded in 2021 and registered in Ostseebad Boltenhagen, Germany, the company targets health-conscious adult consumers and serves them through a single mobile and web product that combines wearable device data with optional blood biomarker analysis to deliver biological age estimation and personalized daily recommendations. The team is small (1–10 employees) and is led by co-founders Floris (data scientist) and Johanna (digital health expert and managing director), with Dr. Fidelius serving as medical advisor (MD, PhD). No revenue, funding rounds, patents, awards, certifications, or enterprise customers are disclosed.

The LONGEVITAL platform is built on three AI/ML components. First, a proprietary BioAge machine learning model trained on data from over 100,000 individuals predicts biological age from 13 to 53 blood markers without using the person's chronological age. Second, an in-house AI-based OCR pipeline running on the company's own servers digitizes blood test results from uploaded photos, eliminating manual data entry. Third, a recommendation engine delivers three personalized daily actions tailored to the user's wearable and blood data, with blood markers evaluated against optimal ranges for longevity rather than population averages. Distribution is via native iOS (13+), native Android (8+), and a browser-based web app, and the product integrates with more than ten validated wearable providers including Apple Watch (Series 7+), Garmin, Oura Ring (Gen3), WHOOP (4.0), and Fitbit. All health data processing runs on SCALEWAY infrastructure in Paris, France, with no third-country transfers outside the EU.

Deyta operates a direct-to-consumer freemium subscription model. Basic registration is free, a 7-day free trial gates the premium tier, and paid subscriptions are priced at €14.99/month or €89.99/year, both of which include daily personalized recommendations and twelve blood marker analyses per year (up to 60 values each). The product is available in English and German and is distributed globally through the app stores, though the legal entity and registered office are in Germany. The company is a single-product, self-serve consumer business with no disclosed B2B revenue, no API for partners, and no integration marketplace beyond the wearable layer.

Name

Deyta

Legal name

Deyta GmbH

Website

https://longevital.de

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Deyta GmbH operates the LONGEVITAL consumer app, using a proprietary BioAge machine learning model and validated wearable integrations to deliver personalized daily longevity recommendations and biological age estimation for health-conscious adult consumers via a global freemium subscription.

Ownership category

akta.pro rank

Product category

Digital Health / Longevity Analytics

akta.pro primary industry

Wearables & Consumer IoT Integration Platforms (BYOD) (HLACAFAF)

akta.pro secondary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

• Longevity analytics
• Biological age tracking
• Blood marker analysis
• Wearable health data
• Personalized health recommendations

Headquarters

HQ city

Ostseebad Boltenhagen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Subscription - Monthly: Premium subscription at €14.99 per month, including daily personalized recommendations and 12 blood marker analyses per year (2 analyses included).
2. Subscription - Annual: Annual premium subscription at €89.99/year (equivalent to ~€7.50/month), providing the same features as monthly plan with a discounted rate.
3. Free Registration: Basic app registration is free, allowing users to explore the platform before upgrading to premium features. This serves as a freemium acquisition channel.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Deyta operates the LONGEVITAL mobile and web application, which combines wearable device data (Apple Watch, Garmin, Oura, WHOOP, Fitbit, and 10+ providers) with optional blood marker analysis (13–53 biomarkers) to estimate a user's biological age via a proprietary ML BioAge clock and deliver three personalized daily recommendations aimed at slowing biological aging. The product is offered on a freemium basis with paid monthly (€14.99) and annual (€89.99) subscriptions that unlock full BioAge estimation, blood marker assessment, and personalized recommendations.

Product overview

Deyta operates as a single-product company with the LONGEVITAL App as its core offering. The product is a holistic longevity optimization platform that combines lifestyle data from validated wearable devices (Apple Watch, Garmin, Oura Ring, WHOOP, Fitbit) with optional blood marker analysis (13-53 biomarkers) to provide personalized daily recommendations and biological age estimation. The platform consists of a mobile app (iOS 13+ and Android 8+) and a web version. Both subscription packages (monthly at €14.99/month or yearly at €89.99/year) include daily personalized recommendations and two blood marker analyses per year (up to 60 values each). The product is available in English and German.

Differentiator

Problem solved

Functional benefit

Products and services

• LONGEVITAL App

Quantifiable outcome

• Analyze up to 53 blood markers against optimal ranges for personalized health assessment
• +3 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability5 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core.

• Apple WatchcoreTechnology or IntegrationValidated wearable integration with Apple Watch (Series 7+). Users can connect their Apple Watch to sync lifestyle data including activity, sleep, and other health metrics for personalized recommendations.
• GarmincoreTechnology or IntegrationValidated integration with most Garmin wearable models, enabling users to connect activity tracking, sleep data, and other health metrics to the LONGEVITAL platform.
• Oura RingcoreTechnology or IntegrationValidated integration with Oura Ring (Gen3), providing users access to detailed sleep, activity, and recovery data for longevity optimization.
• WHOOPcoreTechnology or IntegrationValidated integration with WHOOP (4.0), enabling strain and recovery data integration for personalized longevity recommendations.
• FitbitcoreTechnology or IntegrationValidated integration with most Fitbit models, allowing users to connect their Fitbit data including activity, sleep, and heart rate for comprehensive health tracking.
• SCALEWAYcoreTechnology or IntegrationHosting provider for data processing on SCALEWAY servers located in Paris, France. All health data processing occurs on their infrastructure with no third-country transfers outside the EU.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• InsideTracker: InsideTracker combines blood biomarker analysis with personalized wellness recommendations and longevity-focused scoring, directly competing with LONGEVITAL's biomarker-plus-recommendation core. It is a longer-tenured player in the same consumer longevity analytics category.
• Tally Health: Tally Health centers on biological age testing and longevity interventions for consumers, overlapping directly with LONGEVITAL's biological-age-from-biomarkers proposition. It is a focused direct competitor in the consumer biological age category.
• Elysium: Elysium's Index by Elysium product provides biological age estimation from blood and epigenetic data with longevity-focused interventions, directly comparable to LONGEVITAL's BioAge-from-blood-markers approach. Both compete for the longevity-conscious consumer.
• TruDiagnostic: TruDiagnostic offers epigenetic biological age testing and related longevity analytics to consumers and researchers, overlapping with LONGEVITAL's biological-age estimation core. It provides a comparable analytical product layer in the longevity space.
• Ultrahuman: Ultrahuman combines a smart ring with metabolic and recovery insights, including wearable-driven lifestyle recommendations for health optimization — closely paralleling LONGEVITAL's wearable-driven daily recommendation model.
• Levels: Levels focuses on metabolic health tracking using CGMs and wearable data with personalized recommendations, sharing LONGEVITAL's consumer wellness + wearable-integration + daily recommendation model. It targets the same health-conscious consumer seeking measurable, actionable insights.
• Function Health: Function Health offers comprehensive blood testing with longitudinal biomarker tracking and insights aimed at optimizing healthspan, overlapping directly with LONGEVITAL's biomarker-and-longevity value proposition. It is a recently well-funded direct competitor in the consumer blood biomarker space.

Broad incumbents

• Apple Health: Apple Health aggregates wearable, lab, and lifestyle data on iOS and increasingly surfaces trend insights, making it a broad incumbent whose platform expansion could subsume or compete with third-party longevity analytics layers like LONGEVITAL.
• WHOOP: WHOOP is a consumer wearable platform with strain, recovery, and sleep insights that doubles as a coaching layer; it is both a validated integration partner and a broad incumbent whose own app could expand into LONGEVITAL's recommendation territory.
• Oura: Oura sells a consumer smart ring with readiness and sleep scores and is both a validated LONGEVITAL integration partner and a broad incumbent whose own insights roadmap competes with third-party longevity apps.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deyta